Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer

European Radiology

Volumn 18, Issue 10, 2008, Pages 2040-2047

  Kitajima, Kazuhiro ^a,b   Murakami, Koji ^a   Yamasaki, Erena ^a   Domeki, Yasushi ^a   Kaji, Yasushi ^a   Sugimura, Kazuro ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

18F FDG; Cervical cancer; PET CT; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERMETABOLISM; INTERMETHOD COMPARISON; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 52049116307     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-0979-9     Document Type: Article

References (24)

1. Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone JM Jr, Edwards CL (1988) Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 30:381-387
2. Chou HH, Wang CC, Lai CH (2001) Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. Int J Radiat Oncol Biol Phys 51:442-448
3. Niloff JM, Bast RC Jr, Schaetzl EM, Knapp RC (1985) Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 44:207-212
4. Low RN, Sigeti JS (1994) MR imaging of peritoneal disease: Comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. Am J Roentgenol 163:1131-1140
5. Sugiyama T, Nishida T, Ushijima K et al (1995) Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging. J Obstet Gynecol 21:551-556
6. Forstner R, Hricak H, Powell CB, Azizi L, Frankel SB, Stern JL (1995) Ovarian cancer recurrence: Value of MR imaging. Radiology 196:1131-1140
7. Connor JP, Andrews JI, Anderson B, Buller RE (2000) Computed tomography in endometrial carcinoma. Obstet Gynecol 95:692-696
8. Topuz E, Aydiner A, Saip P et al (2000) Correlation of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer. Eur J Gynecol Oncol 21:599-602
9. Cook GJ, Maisey MN, Fogelman I (1999) Normal variants, artifacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 26:1363-1379
10. Kostakoglu L, Agress H Jr, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315-340
11. Beyer T, Townsend DW, Brun T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369-1379
12. Park DH, Kim KH, Park SY, Lee BH, Choi CW, Chin SY (2000) Diagnosis of recurrent uterine cervical cancer: Computed tomography versus positron emission tomography. Korean J Radiol 1:51-55
13. Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A (2001) Value of whole body 18 F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res 21:2957-2961
14. Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH (2003) Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 44:347-352
15. Nakamoto Y, Eisbruch A, Achtyes ED et al (2002) Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 84:289-295
16. Havrilesky LJ, Wong TZ, Secord AA, Berchuck A, Clarke-Pearson DL, Jones EL (2003) The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 90:186-190
17. Lai CH, Huang KG, See LC et al (2004) Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 100:544-552
18. Chang TC, Law KS, Hong JH et al (2004) Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies.-a phase II study. Cancer 101:164-171
19. Yen TC, See LC, Chang TC et al (2004) Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med 45:1632-1639
20. Chung HH, Jo H, Kang WJ et al (2007) Clinical impact of integrated PET/ CT on the management of suspected cervical cancer recurrence. Gynecol Oncol 104:529-534
21. Sironi S, Picchio M, Landoni C et al (2007) Post-therapy surveillance of patients with uterine cancers: Value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 34:472-479
22. Shim SS, Lee KS, Kim BT et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236:1011-1019
23. Bristow RE, Del Carmen MG, Pannu HK et al (2003) Clinically occult recurrent ovarian cancer: Patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90:519-528
24. 18F-FDG PET imaging in post-therapy monitoring of cervical cancers: From diagnosis to prognosis. J Nucl Med 45:1602-1604